Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
LIFEVANTAGE Aktie jetzt für 0€ handeln | |||||
Mo | Dividendenbekanntmachungen (08.09.2025) | 3.020 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALPHABET INC CDR CA02080K1049 0,0341 CAD 0,0211 EUR ALPHABET INC CL A US02079K3059 0,21 USD 0,1791 EUR ALPHABET INC CL C US02079K1079 0... ► Artikel lesen | |
Fr | LifeVantage falls after earnings miss, LoveBiome revenue outlook unclear | 2 | Seeking Alpha | ||
Fr | LifeVantage outlines $225M-$240M FY26 revenue target amid LoveBiome acquisition and MindBody expansion | 2 | Seeking Alpha | ||
Do | Earnings Call Transkript: LifeVantage übertrifft EPS-Prognose für Q4 2025, Aktie legt deutlich zu | 1 | Investing.com Deutsch | ||
Do | Lifevantage Corp Q4 Profit Increases, But Misses Estimates | - | RTTNews | ||
Do | Lifevantage-Aktie bricht ein: Umsatz im vierten Quartal verfehlt Analystenschätzungen | - | Investing.com Deutsch | ||
Do | LifeVantage Corporation: LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2025 | 65 | GlobeNewswire (Europe) | SALT LAKE CITY, Sept. 04, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the... ► Artikel lesen | |
Do | Lifevantage Corp - 8-K, Current Report | 1 | SEC Filings | ||
Do | Lifevantage Corp - 10-K, Annual Report | 1 | SEC Filings | ||
Mi | LifeVantage Q4 2025 Earnings Preview | 1 | Seeking Alpha | ||
Mi | LifeVantage to acquire microbiome company LoveBiome | 1 | Investing.com | ||
Mi | LifeVantage to acquire LoveBiome | 2 | Seeking Alpha | ||
Mi | LifeVantage Corporation: LifeVantage Announces Acquisition of LoveBiome, Expanding Leadership in Direct Sales, Microbiome Health and Wellness | 1 | GlobeNewswire (USA) | ||
Mi | What's Next: Lifevantage's Earnings Preview | 1 | Benzinga.com | ||
28.08. | LifeVantage Corporation: LifeVantage Declares Quarterly Dividend | 3 | GlobeNewswire (USA) | ||
21.08. | LifeVantage Corporation: LifeVantage to Announce Fourth Quarter and Full Fiscal Year 2025 Results on September 4, 2025 | 2 | GlobeNewswire (USA) | ||
22.07. | Studien: MindBody-System von LifeVantage steigert GLP-1-Spiegel um über 200 % | 1 | Investing.com Deutsch | ||
22.07. | LifeVantage reports 200% GLP-1 increase in MindBody system trials | 1 | Investing.com | ||
22.07. | LifeVantage Corporation: LifeVantage Announces Expanded Human Clinical Study for MindBody GLP-1 System; Findings Increase Average in Natural GLP-1 Production to Over 200%‡‡ | 168 | GlobeNewswire (Europe) | SALT LAKE CITY, July 22, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular... ► Artikel lesen | |
15.07. | LifeVantage Corporation: LifeVantage Hosts Activate 2025, Unveils New Quarterly Business Campaign and Incentive to Drive Global Growth | 2 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
GILEAD SCIENCES | 98,26 | +0,06 % | Aktienmarkt: Kurs der Aktie von Gilead Sciences im Plus (98,5365 €) | Das Wertpapier von Gilead Sciences notiert heute fester. Zuletzt zahlten Investoren für das Papier 115,47 US-Dollar. Die Aktie von Gilead Sciences verzeichnet gegenwärtig einen Wertanstieg von 2,39... ► Artikel lesen | |
AURORA CANNABIS | 4,115 | -1,79 % | Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference | ||
ABBVIE | 177,80 | -1,98 % | Deals im Milliarden-Markt für Psychedelika: AbbVie, Atai Life Sciences, Neural Therapeutics | ||
CANOPY GROWTH | 1,162 | -6,44 % | Canopy Growth Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
ELI LILLY | 615,90 | -0,98 % | Novo Nordisk setzt ein Ausrufezeichen - besser als Eli Lilly | Der dänische Biopharma-Riese hat am Wochenende auf einem Fachkongress im spanischen Madrid weitere Daten zu seinem Adipositas-Medikament Wegovy (Semaglutid) vorgelegt. Novo Nordisk behauptet, dass der... ► Artikel lesen | |
MERCK & CO | 71,70 | -0,83 % | Daiichi Sankyo And Merck: Ifinatamab Deruxtecan Shows Promising Results In Phase 2 ES-SCLC Trial | KENILWORTH (NJ) (dpa-AFX) - Daiichi Sankyo (DSKYF, 4568.T) and Merck & Co Inc. (MRK) announced that Results from the IDeate-Lung01 phase 2 trial showed that ifinatamab deruxtecan (I-DXd) demonstrated... ► Artikel lesen | |
TILRAY BRANDS | 0,943 | -6,75 % | Tilray Aktie: Platzt am Montag die Bombe? Diese Neuigkeiten müssen Anleger dringend beachten! | ||
TEVA | 16,200 | 0,00 % | Teva Pharmaceutical Industries Ltd: Teva to Present at Morgan Stanley Global Healthcare Conference and Bank of America Global Healthcare Conference in September | TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, will present at two upcoming... ► Artikel lesen | |
VERTEX PHARMACEUTICALS | 334,70 | -0,98 % | Is Vertex Pharmaceuticals Stock Underperforming the S&P 500? | ||
ARZNEIWERK AG VIDA | 0,151 | 0,00 % | EQS-HV: Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG | EQS-News: Arzneiwerk AG VIDA
/ Bekanntmachung der Einberufung zur Hauptversammlung
Arzneiwerk AG VIDA: Bekanntmachung der Einberufung zur Hauptversammlung am 04.09.2025 in Berlin... ► Artikel lesen | |
CRONOS GROUP | 2,100 | -0,28 % | Cronos Group Inc.: Cronos Group Reports 2025 Second Quarter Results | Net revenue in Q2 2025 increased by 21% year-over-year PEACE NATURALS® retained its position as the number one cannabis brand in Israel1 Highest-ever international and Israel revenue, fueled by strong... ► Artikel lesen | |
VIATRIS | 8,860 | -1,18 % | Dividendenbekanntmachungen (22.08.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABRDN AUSTRALIA EQUITY FUND INC US0030111035 0,12 USD 0,1033 EUR ACCO BRANDS CORPORATION US00081T1088 0,075 USD 0,0646 EUR ADM... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 11,630 | -2,72 % | EyePoint Pharmaceuticals, Inc.: EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Aug. 18, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
INCYTE | 73,26 | -0,92 % | Incyte stellt Strategie nach Jakafi-Patentablauf vor | ||
BAUSCH HEALTH | 6,272 | +0,05 % | Bausch Health Companies Inc.: Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage Non-Surgical System | LAVAL, QC / ACCESS Newswire / September 5, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global, diversified pharmaceutical company, and Solta Medical, a global leader in the medical aesthetics... ► Artikel lesen |